Your browser doesn't support javascript.
loading
Cryofibrinogen-Associated Glomerulonephritis.
Sethi, Sanjeev; Yachoui, Ralph; Murray, David L; Radhakrishnan, Jai; Alexander, Mariam P.
  • Sethi S; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Yachoui R; Division of Rheumatology, Department of Internal Medicine, Marshfield Clinic, Marshfield, WI.
  • Murray DL; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Radhakrishnan J; Department of Nephrology, Columbia University Medical Center, New York, NY.
  • Alexander MP; Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN. Electronic address: alexander.mariam@mayo.edu.
Am J Kidney Dis ; 69(2): 302-308, 2017 Feb.
Article en En | MEDLINE | ID: mdl-27866967
ABSTRACT
Cryofibrinogen is an under-recognized cryoprotein. Cryofibrinogen is a cryoprecipitate that develops following plasma refrigeration, but does not occur in cold serum. People with cryofibrinogenemia may be asymptomatic, but this cryoprotein can be associated with thromboembolic disease, particularly affecting the skin. Kidney manifestations are relatively uncommon, but are likely underestimated. We describe clinical features and kidney biopsy results in 2 patients with cryofibrinogen-related kidney disease. Both patients presented with proteinuria and hematuria. One had significant cutaneous ulcers and palpable purpura. Kidney biopsy in both cases showed membranoproliferative glomerulonephritis with no immunoglobulin deposition. Weak segmental capillary wall fibrinogen staining was noted in glomeruli. Immunofluorescence studies following pronase digestion failed to reveal masked immunoglobulin deposits. Ultrastructural studies were distinctive and characterized by organized deposits of large-bore with multilayered tubular structures and fine fibrillary structures in a matrix. To confirm the composition of deposits, we extracted the cryoprecipitate from plasma of a patient and performed ultrastructural studies, which showed identical ultrastructural characteristics to those seen on the kidney biopsy. We also performed proteomic analysis of the cryoprecipitate that confirmed the presence of fibrinogen. Subsequent laboratory evaluation was positive for cryofibrinogen in both patients on multiple occasions. Appropriate therapy was instituted in both patients, which included prednisone, immunosuppressive therapy, and avoidance of cold exposure. In summary, we present clinical, kidney biopsy, and laboratory findings and the treatment and follow-up of cryofibrinogen-associated glomerulonephritis. Awareness of this entity will result in accurate diagnoses, appropriate investigation, and treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Crioglobulinas / Fibrinógenos Anormales / Glomerulonefritis Membranoproliferativa Tipo de estudio: Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Crioglobulinas / Fibrinógenos Anormales / Glomerulonefritis Membranoproliferativa Tipo de estudio: Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Año: 2017 Tipo del documento: Article